| Literature DB >> 23893287 |
Mohammed Eyad Yaseen Alsabbagh1, Naseem Eisa, Abdul Hamid Alraiyes, M Chadi Alraies.
Abstract
The combined regimen of peg-interferon α2a plus ribavirin along with protease inhibitors (boceprevir or telaprevir) is considered as a very portent and effective therapy for hepatitis C infections. However, this combined therapy has been associated with a side effect that can make the course of the disease more complicated. In this case, a 50-year-old man developed insulin-dependent diabetes soon after initiating triple hepatitis C therapy. The treatment had to be stopped and the course of his hepatitis C infection has been challenged with this rare side effect.Entities:
Mesh：
Substances：
Year: 2013 PMID： 23893287 PMCID： PMC3736303 DOI： 10.1136/bcr-2013-200514
Source DB: PubMed Journal: BMJ Case Rep ISSN： 1757-790X